CA2205179A1 - Spongiform encephalopathy detection methods - Google Patents

Spongiform encephalopathy detection methods

Info

Publication number
CA2205179A1
CA2205179A1 CA002205179A CA2205179A CA2205179A1 CA 2205179 A1 CA2205179 A1 CA 2205179A1 CA 002205179 A CA002205179 A CA 002205179A CA 2205179 A CA2205179 A CA 2205179A CA 2205179 A1 CA2205179 A1 CA 2205179A1
Authority
CA
Canada
Prior art keywords
apolipoprotein
animal
amount
spongiform encephalopathy
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002205179A
Other languages
English (en)
French (fr)
Inventor
Paula Keyes
Michael Dawson
Trevor Conrad Martin
Verity Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minister of Agriculture Fisheries and Food UK
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9424015A external-priority patent/GB9424015D0/en
Application filed by Individual filed Critical Individual
Publication of CA2205179A1 publication Critical patent/CA2205179A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA002205179A 1994-11-29 1995-11-28 Spongiform encephalopathy detection methods Abandoned CA2205179A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9424015.7 1994-11-29
GB9424015A GB9424015D0 (en) 1994-11-29 1994-11-29 Spongiform encepmalopathy detection methods
GB9424769.9 1994-12-07
GBGB9424769.9A GB9424769D0 (en) 1994-11-29 1994-12-07 Spongiform encephalopathy detection methods

Publications (1)

Publication Number Publication Date
CA2205179A1 true CA2205179A1 (en) 1996-06-06

Family

ID=26306057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002205179A Abandoned CA2205179A1 (en) 1994-11-29 1995-11-28 Spongiform encephalopathy detection methods

Country Status (11)

Country Link
EP (1) EP0795132A1 (sk)
AU (1) AU3932895A (sk)
CA (1) CA2205179A1 (sk)
CZ (1) CZ164297A3 (sk)
FI (1) FI972253A (sk)
GB (1) GB2308659B (sk)
HU (1) HUT77340A (sk)
NO (1) NO972339L (sk)
NZ (1) NZ295721A (sk)
SK (1) SK67897A3 (sk)
WO (1) WO1996017249A1 (sk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2333362B (en) * 1996-10-15 2001-05-16 Imperial College Typing and diagnosis of spongiform encephalopathy
DE934531T1 (de) 1996-10-15 2000-04-06 Imperial College Diagnose spongiformer encephalopathie
GB9701045D0 (en) * 1997-01-18 1997-03-05 Narang Harash K Diagnosis of neuro-degenerative disorders
AU755535B2 (en) * 1998-02-06 2002-12-12 Harash Kumar Narang Diagnosis of neuro-degenerative disorders
FR2827047B1 (fr) * 2001-07-03 2003-09-26 Apoh Technollgies Sa Procede de separation et/ou detection et/ou identification et/ou quantification de proteines prions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias

Also Published As

Publication number Publication date
EP0795132A1 (en) 1997-09-17
WO1996017249A1 (en) 1996-06-06
HUT77340A (hu) 1998-03-30
GB9708663D0 (en) 1997-06-18
FI972253A0 (fi) 1997-05-28
CZ164297A3 (en) 1997-11-12
FI972253A (fi) 1997-07-28
NO972339D0 (no) 1997-05-22
NO972339L (no) 1997-05-22
GB2308659A (en) 1997-07-02
AU3932895A (en) 1996-06-19
NZ295721A (en) 1999-03-29
GB2308659B (en) 1998-11-18
SK67897A3 (en) 2000-02-14

Similar Documents

Publication Publication Date Title
EA004953B1 (ru) Способ обнаружения и выделения аномального прионного белка и набор для его осуществления
Leonardi et al. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis
US20050176078A1 (en) Detection and/or monitoring of synuclein-related diseases
Brechlin et al. Cerebrospinal fluid‐optimized two‐dimensional difference gel electrophoresis (2‐D DIGE) facilitates the differential diagnosis of Creutzfeldt–Jakob disease
US4892814A (en) Method for distinguishing Creutzfeldt-Jakob disease from other dementias
WO1998040748A1 (en) Diagnosing neurologic disorders
US20180120328A1 (en) Biomarker for psychiatric and neurological disorders
KR20190082100A (ko) 보르나바이러스 감염의 진단 방법
Kummrow et al. Serum protein electrophoresis by using high-resolution agarose gel in clinically healthy and Aspergillus species-infected falcons
CA2205179A1 (en) Spongiform encephalopathy detection methods
RU2661022C2 (ru) Изоформы тропомиозина, связанные с болезнью альцгеймера и умеренными когнитивными нарушениями
EP0795133A1 (en) Spongiform encephalopathy detection methods
CN113985035A (zh) 趋化因子ccl28作为标志物在制备干燥综合征诊断试剂中的应用
JP2007132927A (ja) 腹膜機能マーカー、その分析方法およびその用途
US20040175775A1 (en) Method of detecting PrPsc in eye fluid
EP1436618A2 (en) Muscle sample prepared for prion assay
US20030044868A1 (en) Method for detecting prion proteins in tissue samples
Russell et al. Fibrinogen heterogeneity in horses
Hinsinger et al. Syndecan-1 as specific cerebrospinal fluid biomarker of multiple sclerosis
Koyama et al. Novel method for classification of prion diseases by detecting PrPres signal patterns from formalin-fixed paraffin-embedded samples
Brown A search for biomarkers of ovine pre-partum vaginal prolapse: a thesis presented to Massey University in partial fulfilment of the requirement for the degree of Doctor of Philosophy in Biochemistry, Massey University, New Zealand
Gaunitz et al. Suitability of antigens PGP 9.5 and Neurofilament light as marker proteins for detection of neuronal tissue in processed meat products
BG64291B1 (bg) М...'од и ки' за ...к''рахиран... на прион про'...ин
WO2010020037A1 (en) The identification of disease-induced biomarkers in the urine of bse infected cattle

Legal Events

Date Code Title Description
FZDE Discontinued